1. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC;2008.
2. Meloni-Ehrig A. The cytogenetics of hematologic neoplasms. In : Gersen SL, Keagle MB, editors. The principles of clinical cytogenetics. 3rd ed. New York: Springer;2013. p. 309–370.
3. Dyer MJ, Akasaka T, Capasso M, Dusanjh P, Lee YF, Karran EL, et al. Immunoglobulin heavy chain locus chromosomal translocations in B-cell precursor acute lymphoblastic leukemia: rare clinical curios or potent genetic drivers? Blood. 2010; 115:1490–1499. PMID:
20042721.
Article
4. Akasaka T, Balasas T, Russell LJ, Sugimoto KJ, Majid A, Walewska R, et al. Five members of the CEBP transcription factor family are targeted by recurrent IGH translocations in B-cell precursor acute lymphoblastic leukemia (BCP-ALL). Blood. 2007; 109:3451–3461. PMID:
17170124.
Article
5. Harrison CJ. Cytogenetics of paediatric and adolescent acute lymphoblastic leukaemia. Br J Haematol. 2009; 144:147–156. PMID:
19006567.
Article
6. Chapiro E, Radford-Weiss I, Cung HA, Dastugue N, Nadal N, Taviaux S, et al. Chromosomal translocations involving the IGH@ locus in B-cell precursor acute lymphoblastic leukemia: 29 new cases and a review of the literature. Cancer Genet. 2013; 206:162–173. PMID:
23827691.
Article
7. Moorman AV, Schwab C, Ensor HM, Russell LJ, Morrison H, Jones L, et al. IGH@ translocations, CRLF2 deregulation, and microdeletions in adolescents and adults with acute lymphoblastic leukemia. J Clin Oncol. 2012; 30:3100–3108. PMID:
22851563.
Article
8. Wlodarska I, Matthews C, Veyt E, Pospisilova H, Catherwood MA, Poulsen TS, et al. Telomeric IGH losses detectable by fluorescence in situ hybridization in chronic lymphocytic leukemia reflect somatic VH recombination events. J Mol Diagn. 2007; 9:47–54. PMID:
17251335.
Article
9. Trakhtenbrot L, Hardan I, Koren-Michowitz M, Oren S, Yshoev G, Rechavi G, et al. Correlation between losses of IGH or its segments and deletions of 13q14 in t(11;14) (q13;q32) multiple myeloma. Genes Chromosomes Cancer. 2010; 49:17–27. PMID:
19787791.
10. Fink SR, Paternoster SF, Smoley SA, Flynn HC, Geyer SM, Shanafelt TD, et al. Fluorescent-labeled DNA probes applied to novel biological aspects of B-cell chronic lymphocytic leukemia. Leuk Res. 2005; 29:253–262. PMID:
15661260.
Article
11. Hwang Y, Lee JY, Mun YC, Seong CM, Chung WS, Huh J. Various patterns of IgH deletion identified by FISH using combined IgH and IgH/CCND1 probes in multiple myeloma and chronic lymphocytic leukemia. Int J Lab Hematol. 2011; 33:299–304. PMID:
21272268.
Article
12. Quintero-Rivera F, Nooraie F, Rao PN. Frequency of 5' IGH deletions in B-cell chronic lymphocytic leukemia. Cancer Genet Cytogenet. 2009; 190:33–39. PMID:
19264231.
13. Hutspardol S, Pakakasama S, Kanta K, Nuntakarn L, Anurathapan U, Sirachainan N, et al. Interphase-FISH screening for eight common rearrangements in pediatric B-cell precursor acute lymphoblastic leukemia. Int J Lab Hematol. 2013; 35:406–415. PMID:
23190578.
Article
14. Dyer MJ, Heward JM, Zani VJ, Buccheri V, Catovsky D. Unusual deletions within the immunoglobulin heavy-chain locus in acute leukemias. Blood. 1993; 82:865–871. PMID:
8338950.
Article
15. Paulsson K, Heidenblad M, Mörse H, Borg A, Fioretos T, Johansson B. Identification of cryptic aberrations and characterization of translocation breakpoints using array CGH in high hyperdiploid childhood acute lymphoblastic leukemia. Leukemia. 2006; 20:2002–2007. PMID:
16990785.
Article
16. Shaffer LG, Jordan JM, Schmid M, editors. An international System for human cytogenetic nomenclature. Basel: S. Karger;2013.
17. Reindl L, Bacher U, Dicker F, Alpermann T, Kern W, Schnittger S, et al. Biological and clinical characterization of recurrent 14q deletions in CLL and other mature B-cell neoplasms. Br J Haematol. 2010; 151:25–36. PMID:
20649559.
Article